Dr. Ronald T. Ackerman Sr., MD

Dr. Ackerman practices at Raulerson GYN in Loxahatchee, Florida.

Dr. Ackerman's NPI, 1942356621, was assigned on January 26, 2007. Dr. Ackerman graduated from Universidad Autonoma de Guadalajara in 1978. Dr. Ackerman holds Florida license ME0043294.

Dr. Ackerman's primary practice is Raulerson GYN, at 12953 Palms West Dr, Loxahatchee, FL 33470 in Palm Beach County. The practice phone is (863) 763-8000.

Dr. Ackerman's primary practice is Raulerson GYN in Loxahatchee, Florida. The medical group on file is Raulerson GYN. Dmand AI also links Dr. Ackerman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ackerman practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecology is Dr. Ackerman's primary specialty in the NPI Registry, under taxonomy code 207VG0400X. Dr. Ackerman is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Ackerman's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists menopause, pelvic prolapse, UTI and vaginal infection among the conditions Dr. Ackerman treats.

CMS data shows 28 Medicare services from Dr. Ackerman across 1 procedure code in 2023, all of them office visits, for 19 Medicare patients. Medicare paid $1,724 for them. Every service was in an office.

CMS counts 19 Medicare patients who saw Dr. Ackerman in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.75, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ackerman's median patient age at 51, with 98% women.

In 2024, Dr. Ackerman wrote 96 Medicare Part D claims for 27 patients. 81% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $379 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ackerman for performance year 2024, reported as part of a group. Dr. Ackerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Ackerman, published from 2013 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Double-Blind Method, Estradiol and Hot Flashes. Dr. Ackerman has published most often in J Clin Microbiol. Dr. Ackerman's most frequent co-authors are Bruce R. Carr, MD, Eve C. Feinberg, MD and William David Koltun, MD.

Dmand AI links Dr. Ackerman to 13 clinical trials, 8 of them phase 3 studies. Conditions studied include COVID-19, Squamous Intraepithelial Lesions and Vaginitis. GlaxoSmithKline sponsors the most, 2.

CMS Open Payments shows 92 general payments to Dr. Ackerman from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Eli Lilly and Company paid the most, $4,412. It also lists 21 research payments totaling $247,448 from 2016 to 2017.

Dmand AI lists 1 award for Dr. Ackerman.

Dr. Ackerman graduated from Universidad Autonoma de Guadalajara in 1978. Dr. Ackerman is a member of American College of Obstetricians and Gynecologists and SLS.

Dr. Ackerman is in network with 11 carriers, including Aetna, Elevance and Cigna. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.